These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 32799195)

  • 1. Malignancies in Inflammatory Bowel Disease.
    Greuter T; Vavricka S; König AO; Beaugerie L; Scharl M;
    Digestion; 2020; 101 Suppl 1():136-145. PubMed ID: 32799195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extra-intestinal malignancies in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (III).
    Magro F; Peyrin-Biroulet L; Sokol H; Aldeger X; Costa A; Higgins PD; Joyce JC; Katsanos KH; Lopez A; de Xaxars TM; Toader E; Beaugerie L
    J Crohns Colitis; 2014 Jan; 8(1):31-44. PubMed ID: 23721759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-TNF agents in patients with inflammatory bowel disease and malignant melanoma--challenges in management.
    Lee J; Clarke K
    Int J Colorectal Dis; 2015 Dec; 30(12):1595-602. PubMed ID: 26349591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of cancer in inflammatory bowel disease: going up, going down, or still the same?
    Garg SK; Loftus EV
    Curr Opin Gastroenterol; 2016 Jul; 32(4):274-81. PubMed ID: 27152873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignancies in inflammatory bowel disease.
    Nieminen U; Färkkilä M
    Scand J Gastroenterol; 2015 Jan; 50(1):81-9. PubMed ID: 25523559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignancies in Patients with Inflammatory Bowel Disease: A Single-Centre Experience.
    Madanchi M; Zeitz J; Barthel C; Samaras P; Scharl S; Sulz MC; Biedermann L; Frei P; Vavricka SR; Rogler G; Scharl M
    Digestion; 2016; 94(1):1-8. PubMed ID: 27318857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring for Extra-Intestinal Cancers in IBD.
    Sifuentes H; Kane S
    Curr Gastroenterol Rep; 2015 Nov; 17(11):42. PubMed ID: 26364836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal and Extraintestinal Cancers Associated With Inflammatory Bowel Disease.
    Chang M; Chang L; Chang HM; Chang F
    Clin Colorectal Cancer; 2018 Mar; 17(1):e29-e37. PubMed ID: 28712945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do inflammatory bowel disease therapies cause cancer?
    Mason M; Siegel CA
    Inflamm Bowel Dis; 2013 May; 19(6):1306-21. PubMed ID: 23470503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatment.
    Axelrad JE; Lichtiger S; Yajnik V
    World J Gastroenterol; 2016 May; 22(20):4794-801. PubMed ID: 27239106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Lymphoma, Colorectal and Skin Cancer in Patients with IBD Treated with Immunomodulators and Biologics: A Quebec Claims Database Study.
    Kopylov U; Vutcovici M; Kezouh A; Seidman E; Bitton A; Afif W
    Inflamm Bowel Dis; 2015 Aug; 21(8):1847-53. PubMed ID: 25993693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
    Cheddani H; Dauchet L; Fumery M; Charpentier C; Marie Bouvier A; Dupas JL; Pariente B; Peyrin-Biroulet L; Savoye G; Gower-Rousseau C
    Am J Gastroenterol; 2016 Oct; 111(10):1428-1436. PubMed ID: 27481308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, management, and course of cancer in patients with inflammatory bowel disease.
    Algaba A; Guerra I; Marín-Jiménez I; Quintanilla E; López-Serrano P; García-Sánchez MC; Casis B; Taxonera C; Moral I; Chaparro M; Martín-Rodríguez D; Martín-Arranz MD; Manceñido N; Menchén L; López-Sanromán A; Castaño Á; Bermejo F
    J Crohns Colitis; 2015 Apr; 9(4):326-33. PubMed ID: 25687203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What Should Be Done in Inflammatory Bowel Disease Patients with Prior Malignancy?
    Cosnes J
    Dig Dis; 2017; 35(1-2):50-55. PubMed ID: 28147366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of Immunomodulators and Biologic Agents on Malignancy in Patients with Inflammatory Bowel Disease].
    Kim JH; Kim JW
    Korean J Gastroenterol; 2017 Oct; 70(4):162-168. PubMed ID: 29060953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of malignancies in patients with inflammatory bowel disease treated with thiopurines or anti-TNF alpha antibodies.
    Beigel F; Steinborn A; Schnitzler F; Tillack C; Breiteneicher S; John JM; Van Steen K; Laubender RP; Göke B; Seiderer J; Brand S; Ochsenkühn T
    Pharmacoepidemiol Drug Saf; 2014 Jul; 23(7):735-44. PubMed ID: 24788825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of malignant tumors in patients with inflammatory bowel disease].
    Meyer L; Simian D; Kronberg U; Estay C; Lubascher J; Figueroa C; Quera R
    Rev Med Chil; 2015 Jul; 143(7):834-40. PubMed ID: 26361018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of cancer in IBD - a balancing act.
    Mill J; Lawrance IC
    Minerva Gastroenterol Dietol; 2013 Sep; 59(3):261-72. PubMed ID: 23867946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric inflammatory bowel diseases and the risk of lymphoma: should we revise our treatment strategies?
    Cucchiara S; Escher JC; Hildebrand H; Amil-Dias J; Stronati L; Ruemmele FM
    J Pediatr Gastroenterol Nutr; 2009 Mar; 48(3):257-67. PubMed ID: 19274777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignancies in Inflammatory Bowel Disease: Frequency, Incidence and Risk Factors-Results from the Swiss IBD Cohort Study.
    Scharl S; Barthel C; Rossel JB; Biedermann L; Misselwitz B; Schoepfer AM; Straumann A; Vavricka SR; Rogler G; Scharl M; Greuter T
    Am J Gastroenterol; 2019 Jan; 114(1):116-126. PubMed ID: 30333538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.